DENTSPLY SIRONA director granted 22,822 RSUs

DENTSPLY SIRONA Inc. director Michael J. Barber reported a compensation-related equity grant on Common Stock.

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Michael J. Barber reported a compensation-related equity grant on Common Stock. He acquired 22,822 shares at a stated price of $0.00 per share, bringing his direct holdings to 40,768 shares after the transaction.

According to the footnote, this grant consists entirely of Restricted Stock Units that vest in full one year from the grant date, meaning the restrictions lapse at that time if service conditions are met.

Insider Trade Summary

Grant/Award: 22,822 shares

Grant/Award 1 txn

Insider Barber Michael J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,822	$0.00	$0.00

Holdings After Transaction: Common Stock — 40,768 shares (Direct)

Footnotes (1)

1. F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Key Figures

RSU grant size: 22,822 shares Holdings after grant: 40,768 shares Grant price per share: $0.00 per share +1 more

4 metrics

RSU grant size 22,822 shares Restricted Stock Units awarded to Michael J. Barber

Holdings after grant 40,768 shares Total direct DENTSPLY SIRONA common shares after transaction

Grant price per share $0.00 per share Compensation-related award, not an open-market purchase

Vesting period One year RSUs vest in full one year from grant date

Key Terms

Restricted Stock Units (RSUs), Form 4, transaction code A, Grant, award, or other acquisition, +1 more

5 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Form 4 regulatory

"INSIDER FILING DATA (Form 4): { "issuerName": "DENTSPLY SIRONA Inc."..."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code A regulatory

""transaction_code": "A", "transaction_code_description": "Grant, award, or other acquisition""

Grant, award, or other acquisition financial

""transaction_code_description": "Grant, award, or other acquisition""

vest in full financial

"RSUs that vest in full (restrictions lapse) one year from date of grant."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did XRAY director Michael J. Barber report in this Form 4?

Michael J. Barber reported receiving an equity grant tied to DENTSPLY SIRONA Inc. common stock. The award covers 22,822 shares, classified as a grant or award acquisition, and increased his direct holdings to 40,768 shares following the transaction, according to the Form 4 data.

How many DENTSPLY SIRONA (XRAY) shares were granted to Michael J. Barber?

The Form 4 shows Michael J. Barber was granted 22,822 shares related to DENTSPLY SIRONA common stock. These were recorded with a transaction price of $0.00 per share, reflecting a compensation-related award rather than a market purchase, and increased his total direct holdings.

What is Michael J. Barber’s XRAY shareholding after this reported grant?

After the reported grant, Michael J. Barber directly holds 40,768 DENTSPLY SIRONA common shares. This total includes the 22,822-share award disclosed in the filing, giving investors a clearer view of his updated equity position as a company director based on the reported data.

What type of award did Michael J. Barber receive from DENTSPLY SIRONA (XRAY)?

The filing footnote states the award consists entirely of Restricted Stock Units, or RSUs. These RSUs relate to DENTSPLY SIRONA common stock and are structured as a compensation grant, with no cash paid by Barber at grant based on the $0.00 transaction price.

When do Michael J. Barber’s DENTSPLY SIRONA RSUs from this grant vest?

The RSUs from this grant vest in full one year from the date of grant. The footnote explains that restrictions lapse at that one-year mark, meaning the units fully vest at that time if the applicable service conditions continue to be satisfied.

Was Michael J. Barber’s XRAY transaction an open-market purchase or a grant?

This transaction is categorized as a grant or award acquisition, not an open-market purchase. The Form 4 uses transaction code A, with a price of $0.00 per share, and a footnote describing the award as Restricted Stock Units granted as part of compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Barber Michael J

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NORTH CAROLINA 28277

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		22,822(1)	A	$0	40,768	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Michael J. Barber	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)